
Larry Low Counsel
San Francisco
San Francisco
San Francisco
As a partner, he represented public and private high growth technology companies, and venture capital funds in a broad range of industries including, energy, semiconductors, Internet, software and consumer products. He has extensive experience in start-up enterprises, venture financings, public offerings, mergers and acquisitions, and has advised companies and investors in cross border transactions involving Asia.
Larry was appointed in 1995 by President Clinton as one of four U.S. representatives to serve on the panel of arbitrators of the International Centre for the Settlement of Investment Disputes. He has served as an officer and board member for numerous non-profit organizations. From 2021 to 2023, he served as the Chief Operating Officer of Ascend, the largest network of Asian professionals.
Larry has published articles that have appeared in publications of the California Continuing Education of the Bar and the Practicing Law Institute. He has made presentations to the Practicing Law Institute, Law Journal Seminars, Silicon Valley Association of Start up Entrepreneurs, University of California College of the Law, San Francisco, University of California at Berkeley, Haas Business School, UC Berkeley Law and the California State Bar among others. He was a lecturer at Stanford Law School during the Fall of 2024.
Los Angeles
Primary Focus & Experience
Dr. Lu’s practice focuses on patent, trade secrets, and life sciences litigation. He has represented clients in matters involving patent infringement, U.S.-China trade secret misappropriation, biosimilars, ANDA litigation, and licensing disputes. He also represents clients in connection with proceedings before the Patent Trial and Appeal Board. His clients have included Genentech, Tris Pharma, Rosenberger, and Natera.
Recognition & Accomplishments
Dr. Lu has been on the editorial advisory board for Law360 Life Science publications and was named to Benchmark Litigation’s “40 and Under Hot List,” which honors the achievements of the nation’s most accomplished litigators under 40. He was also named to the Southern California Rising Stars list by Super Lawyers.
Dr. Lu has authored a number of publications, including: “Thryv: opposing policies in the Supreme Court,” World Intellectual Property Review (June 5, 2020); “The Growth of Online Universities: How to Solve the Accreditation Dilemma, Protect Students, and Expand Access to Higher Education,” a chapter in “Education and Social Media: Toward a Digital Future,” MIT Press (2016); “Senate Gridlock Causes En Banc Uncertainty,” and “Intellectual Property Special Report,” The Recorder (July 15, 2013); and “Promotion and Market Share in the Proton Pump Inhibitor Market: A Case Study,” Journal of Pharmaceutical Marketing & Management, Volume 17, Issue 3, 39-59 (2007).
Dr. Lu is the chair of the board of directors for Asian Pacific American Dispute Resolution Center (APADRC), a nonprofit organization. He was also a Fellow of the Leadership Council on Legal Diversity.
Prior to private practice, Dr. Lu was a law clerk to the Honorable William Alsup of the U.S. District Court for the Northern District of California.
Dr. Lu received his J.D. from Yale Law School, where he was Notes Editor of the Yale Law Journal and Executive Editor of the Yale Journal of Law & Technology. While in law school, he was an extern for the Honorable John T. Noonan of the U.S. Court of Appeals for the Ninth Circuit, and an intern for the U.S. Attorney’s Office for the District of Connecticut.
Prior to law school, Dr. Lu earned his Doctor of Pharmacy, with highest distinction, from the University of North Carolina, and worked in pharmaceutical marketing.
Dr. Lu is conversant in Mandarin Chinese.
San Francisco
Cathy also engages in complex commercial litigation including employee mobility, breach of contract, and fraud cases. Her matters are often high-profile and industry-changing. Cathy's practice also includes trade secrets investigations as well as counseling on joint ventures, mergers and acquisitions, third-party vendor relationships, and emerging technology to help minimize the risk to companies. Cathy has significant experience in actions arising from the Defend Trade Secrets Act (DTSA), which created the first federal civil misappropriation of trade secrets claim in May 2016. Cathy has helped shape DTSA law on behalf of her clients through her involvement in some of the earliest DTSA litigation. Many of her trade secrets cases involve parallel criminal proceedings.
For her achievements, Legal 500 recognized Cathy as a "Leading Lawyer" in trade secrets in 2024. The National Asian Pacific American Bar Association also honored Cathy as a 2019 Best Lawyer Under 40. This annual list recognizes individuals within the APA community who have achieved prominence or distinction in their field and demonstrated a strong commitment to the APA community or civic affairs.
Cathy also regularly speaks and writes about trade secrets issues. She previously served as the Co-Vice Chair of the Trade Secrets Interest Group of the California Lawyers Association's (formerly of the California State Bar) Intellectual Property Section and she writes an annual column about trade secret hot topics in the CLA's "New Matter" publication.
Cathy is very active within the firm and her community. Cathy previously served as the Hiring Partner for the San Francisco office. Orrick selected Cathy to serve as the firm's 2020 Fellow for the Leadership Council on Legal Diversity, and Cathy previously served as the Co-Chair of the Asian American Bar Association's Judiciary Committee, which is focused on increasing representation on the bench.
Cathy also maintains an active pro bono practice. Cathy's dedication to pro bono service was demonstrated by her work in an asylum merits hearing representing a Salvadoran religious activist persecuted by gangs in El Salvador. For her work on this matter, the Lawyers Committee for Civil Rights honored Cathy with the Father Cuchulain Moriarity Award. In addition, the Justice & Diversity Center of the Bar Association of San Francisco recognized Cathy as an Outstanding Volunteer in Public Service in 2014 through 2020 for her work with helping homeless clients remove outstanding warrants barring them from access to housing and employment.
Washington, D.C.
Emily routinely handles all aspects of civil and class action litigation, from early motions practice to trial before a jury or arbitration panel. Her extensive litigation practice concentrates on antitrust and competition law, and she has represented plaintiffs, defendants, and third parties in high-stakes matters.
In addition to her litigation practice, Emily also advises clients on a spectrum of critical antitrust and competition matters, spanning government investigations, merger clearance, and strategic counseling. She adeptly navigates clients through the intricacies of regulatory inquiries and enforcement actions, specifically from the FTC and DOJ. She represents clients across a diverse range of industries, including technology, healthcare and life sciences, automotive, oil & gas, and professional membership organizations.
Notably, Emily has developed a focus on issues at the intersection of antitrust and intellectual property, with a particular emphasis on standards-essential patents (SEPs) subject to a commitment to license on fair, reasonable, and nondiscriminatory terms (FRAND). In addition to representing clients in licensing negotiations, litigation matters, and government outreach with respect to SEPs and FRAND, she has authored extensive thought leadership on this topic.
Prior to law school, Emily worked as a research assistant and project coordinator at the Brookings Institution in Washington, D.C.
London
He regularly advises on IPOs, direct listings, follow-ons, de-SPACs, reverse mergers and takeovers on UK, U.S. and European stock exchanges, domestic and cross-border public and private M&A deals, venture capital, private and growth equity investments, debt financings, joint ventures, carve-outs, and restructurings, as well as on governance, disclosure, compliance, and strategic advisory matters.
His broad industry experience includes working with clients in the AI and technology, healthcare and life sciences, logistics, retail, media, marketing, financial services, energy and natural resources sectors.
San Francisco
San Francisco
Ashley works on single plaintiff and class action cases, defending against discrimination, harassment, retaliation, and wage claims. She also advises employers on employment policies and practices, including compliance with evolving pay transparency laws.
Before becoming a lawyer, Ashley worked in education. She was also a 2020 Pro Bono Orrick Fellow at the Legal Aid Society of San Mateo County, where she practiced eviction defense and special education law.
Silicon Valley
Jing’s practice is primarily focused on patent and trade secret litigation. Her experience covers a broad range of technologies including small molecules (salts, polymorphs, formulations, and process patents) and biologic drugs, medical devices, diagnostics, software, and semiconductors. She has worked on Hatch Waxman (ANDA) litigation as well as Biologics Price Competition and Innovation Act (BPCIA) cases defending multi-billion-dollar diabetes and cancer drugs from generic/biosimilar challenges. Her clients have ranged from big pharmaceutical companies, to biotechnology companies, to pre-IPO startups, which uniquely positions her to counsel companies at all stages on portfolio strategy. Jing’s extensive background in biosciences, including years of laboratory research experience, serves her clients well in high-stakes matters before the Patent Trial and Appeal Board, U.S. District Courts, and Federal Circuit. Recently, Jing helped defend the validity of all challenged claims in a salt/polymorph patent in an IPR and was instrumental in developing parallel district court cases for a blockbuster diabetes drug.
Alongside her intellectual property practice, Jing has the privilege of using her Federal Circuit experience to represent veterans pro bono in their appeals to the court.
Prior to joining Orrick, Jing served as a judicial law clerk for Judge Raymond T. Chen at the U.S. Court of Appeals for the Federal Circuit and was an associate at a Vault 100 litigation boutique in Washington, D.C. Before law school, Jing was a Marshall Scholar, and she pursued dual graduate degrees in biosciences and policy studies while conducting public policy research in the U.K. and the United States.